Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

322 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Active, Not Recruiting

Clinical Study of Neflamapimod in Patients With Primary Progressive Aphasia

NCT07033481

Conditions
Aphasia, Aphasia, Primary Progressive, Behavior, +24 more
Locations
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Columbia University New York, United States
  • The Ohio State University Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

NCT04838301

Conditions
Alzheimer Dementia, Alzheimer Disease, Brain Diseases, +8 more
Locations
  • Perseverance Research Center Scottsdale, Arizona, United States
  • University of Arizona / Clinical & Translational Sciences Research Center Tucson, Arizona, United States
  • ATP Clinical Research Costa Mesa, California, United States
  • Syrentis Clinical Research Santa Ana, California, United States
View Trial Details
Active, Not Recruiting

A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)

NCT05738486

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations
  • MD First Research - Chandler Chandler, Arizona, United States
  • Irvine Clinical Research Irvine, California, United States
  • Healthy Brain Clinic Long Beach, California, United States
  • California Neuroscience Research Medical Group, Inc. Sherman Oaks, California, United States
View all 49 locations
View Trial Details
Active, Not Recruiting

Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants

NCT05469360

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • Novartis Investigative Site Kuopio, Finland
  • Novartis Investigative Site Turku, Finland
  • Novartis Investigative Site Lille, France
  • Novartis Investigative Site Paris, France
View Trial Details
Active, Not Recruiting

Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD

NCT05819359

Conditions
Basal Ganglia Diseases, Behavior, Brain Diseases, +9 more
Locations
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • Cedars-Sinai Los Angeles, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 95 locations
View Trial Details
Active, Not Recruiting

A Study of Lu AF82422 in Participants With Multiple System Atrophy

NCT05104476

Conditions
Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +8 more
Locations
  • The Parkinsons and Movement Disorder Institute Fountain Valley, California, United States
  • University of California - San Diego La Jolla, California, United States
  • University of California, San Francisco Neurosciences Clinical Research Unit San Francisco, California, United States
  • CenExel Rocky Mountain Clinical Research, LLC Englewood, Colorado, United States
View all 19 locations
View Trial Details

Related conditions